| scholarly article | Q13442814 |
| P2093 | author name string | Yu Yang | |
| Ke Li | |||
| Lixiu Yu | |||
| Qilin Zhang | |||
| LiLi Yu | |||
| Xiaoli Hua | |||
| P2860 | cites work | E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells | Q43107815 |
| Early stage epithelial ovarian cancers: a study of morphologic prognostic factors | Q44033648 | ||
| Association of reduced immunohistochemical expression of E-cadherin with a poor ovarian cancer prognosis--results of a meta-analysis | Q44413954 | ||
| Prognostic and predictive values of E-cadherin for patients of ovarian clear cell adenocarcinoma | Q44487849 | ||
| Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma | Q46464974 | ||
| Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer | Q46975204 | ||
| Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas | Q48715587 | ||
| The Associations of Genetic Variants in E-cadherin Gene With Clinical Outcome of Epithelial Ovarian Cancer. | Q51364405 | ||
| Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. | Q53260738 | ||
| Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. | Q53358319 | ||
| E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis | Q54676964 | ||
| Cancer survival in the developing world | Q58218186 | ||
| [Abnormal E-cadherin expression as a risk factor for deep myometrial invasion and lymph node metastasis in endometrial carcinoma] | Q71944254 | ||
| Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion | Q72430757 | ||
| Detecting and describing heterogeneity in meta-analysis | Q74573466 | ||
| Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma | Q79799789 | ||
| Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas | Q80563630 | ||
| The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer | Q83291477 | ||
| Roles of E-cadherin and cyclooxygenase enzymes in predicting different survival patterns of optimally cytoreduced serous ovarian cancer patients | Q85895035 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? | Q24628819 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| E-cadherin and gastric cancer: cause, consequence, and applications | Q27000278 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Cell adhesion: the molecular basis of tissue architecture and morphogenesis | Q28276573 | ||
| Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature | Q29614233 | ||
| Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites | Q33748623 | ||
| Impact of p120-catenin isoforms 1A and 3A on epithelial mesenchymal transition of lung cancer cells expressing E-cadherin in different subcellular locations | Q35088454 | ||
| Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer | Q35769582 | ||
| Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma | Q35854310 | ||
| The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis | Q35986338 | ||
| Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton | Q35988878 | ||
| Ovarian cancer biomarkers: current options and future promise | Q36054395 | ||
| Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis | Q36266501 | ||
| The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients | Q36614683 | ||
| Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer | Q36855239 | ||
| Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer | Q37589190 | ||
| Cancer survival: global surveillance will stimulate health policy and improve equity | Q38172320 | ||
| The network of epithelial-mesenchymal transition: potential new targets for tumor resistance | Q38255668 | ||
| Cadherins: The Superfamily Critically Involved in Breast Cancer | Q38716173 | ||
| Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. | Q38803572 | ||
| Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression | Q39861128 | ||
| Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. | Q39951465 | ||
| Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells | Q40414876 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 81176-81185 | |
| P577 | publication date | 2017-09-14 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer | |
| P478 | volume | 8 |
Search more.